Access the full text.
Sign up today, get DeepDyve free for 14 days.
L. Wallentin, R. Becker, A. Budaj, C. Cannon, H. Emanuelsson, C. Held, J. Horrow, S. Husted, S. James, H. Katus, K. Mahaffey, B. Scirica, A. Skene, P. Steg, R. Storey, R. Harrington, A. Freij, M. Thorsén (2009)
Ticagrelor versus clopidogrel in patients with acute coronary syndromes.The New England journal of medicine, 361 11
P. Ridker, E. Danielson, F. Fonseca, J. Genest, A. Gotto, J. Kastelein, W. Koenig, P. Libby, A. Lorenzatti, Jean Macfadyen, B. Nordestgaard, J. Shepherd, J. Willerson, R. Glynn (2008)
Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.The New England journal of medicine, 359 21
L. Breiman (2001)
Random ForestsMachine Learning, 45
Xiwu Lin, D. Parks, Lei Zhu, L. Curtis, H. Steel, Andrew Rut, V. Mooser, L. Cardon, A. Menius, Kwan Lee (2012)
Truncated Robust Distance for Clinical Laboratory Safety Data Monitoring and AssessmentJournal of Biopharmaceutical Statistics, 22
AndrewJ. Coats (2002)
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trialThe Lancet, 360
J. Friedman (2001)
Greedy function approximation: A gradient boosting machine.Annals of Statistics, 29
K. Penny, I. Jolliffe (2001)
A comparison of multivariate outlier detection methods for clinical laboratory safety dataThe Statistician, 50
H. Southworth (2008)
Detecting Outliers in Multivariate Laboratory DataJournal of Biopharmaceutical Statistics, 18
O. Amit, R. Heiberger, P. Lane (2008)
Graphical approaches to the analysis of safety data from clinical trialsPharmaceutical Statistics, 7
S. Berry, D. Berry (2004)
Accounting for Multiplicities in Assessing Drug Safety: A Three‐Level Hierarchical Mixture ModelBiometrics, 60
S. Yusuf (2002)
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial. CommentaryThe Lancet, 360
Harry Southworth, M. O’Connell (2009)
Data Mining and Statistically Guided Clinical Review of Adverse Event Data in Clinical TrialsJournal of Biopharmaceutical Statistics, 19
D. Firth (1993)
Bias reduction of maximum likelihood estimatesBiometrika, 80
[Clinical trials collect a great deal of data relating to the safety of the trial participants. The data are complex in nature and traditional approaches to data review involve using summary tables and listed data. An alternative approach to the review of clinical trial safety data is presented, allowing reviewers to access individual subject data via hyperlinked plots and tables. Examples of presentations of data for very large studies, and of the inclusion outputs from modern statistical methods are demonstrated.]
Published: Sep 28, 2012
Keywords: Random Forest; Patient Report; Graphical Presentation; Patient Identifier; Scalable Vector Graphic
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.